Stay in Touch
To keep in touch, please sign up to the Milltrust Ventures Newsletter for our latest news and insights.
A chat with Sir David Lane on COVID-19 immunity and antibody drugs
Leading antibody expert and chief scientist of Singapore’s Agency for Science, Technology and Research, and advisor to Milltrust in Singapore, Professor Sir David Lane discusses COVID-19 immunity, antibody drugs, and the ethical and legal implications that may arise from granting ‘immunity certificates’ for travel and work.
Tags: Commentary Healthcare Milltrust Science